Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Department of Agriculture plans to purchase up to $472.5 million in domestically produced food commodities for distribution through charitable food networks and federal nutrition assistance …
USDA Plans $472.5 Million in Farm Purchases to Support Markets Read More
WASHINGTON, D.C. — In case you missed it, the U.S. Food and Drug Administration granted accelerated approval last week to Inovio Pharmaceuticals’ Voceryq, the first plasmid DNA-based immunotherapy authorized in …
ICYMI: FDA Clears First DNA Immunotherapy for Rare Airway Disease Read More
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) has secured priority review from the U.S. Food and Drug Administration for its experimental treatment of microcystic lymphatic malformations, putting the Wayne-based …
Palvella Wins Priority FDA Review for Rare Disease Drug Read More PLYMOUTH MEETING, PA — INOVIO (Nasdaq: INO) has secured U.S. Food and Drug Administration accelerated approval for VOCERYQ, the first plasmid DNA-based immunotherapy authorized in the United States, giving the …
FDA Approves INOVIO’s First DNA Immunotherapy for Rare Disease Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has received U.S. Food and Drug Administration Breakthrough Device Designation for its Freesolve Resorbable Magnesium Scaffold in coronary artery procedures, potentially accelerating the …
Teleflex Secures FDA Breakthrough Status for Heart Device Read More
PHILADELPHIA, PA — GSK plc (NYSE: GSK) secured U.S. Food and Drug Administration approval for Hibsago, a hepatitis B treatment that achieved functional cure in 19% of eligible clinical trial …
FDA Approves GSK’s Hibsago for Chronic Hepatitis B Read More PHILADELPHIA, PA — The U.S. Food and Drug Administration has granted accelerated approval to GSK’s Jemperli as a standalone treatment for certain patients with locally advanced rectal cancer, creating an …
FDA Approves GSK’s Jemperli for Certain Rectal Cancer Patients Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has received clearance from the U.S. Food and Drug Administration to resume clinical development of its experimental hepatitis B treatment AB-101 in …
Arbutus Wins FDA Clearance to Resume Hepatitis B Drug Trials Read More
WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) has completed commercial-scale manufacturing validation for its preservative-free injectable ketamine, positioning the company to begin supplying U.S. hospitals and clinics if the …
NRx Clears Manufacturing Hurdle for Ketamine FDA Review Read More
WEST CHESTER, PA — Centinel Spine has secured U.S. Food and Drug Administration approval to use its prodisc C Nova artificial cervical disc at two levels of the spine, expanding …
West Chester Medical Firm Gains Ground With FDA Decision Read More